Targeting Nodal in malignant melanoma cells - PubMed (original) (raw)
Review
Targeting Nodal in malignant melanoma cells
Lynne-Marie Postovit et al. Expert Opin Ther Targets. 2007 Apr.
Abstract
Metastatic melanoma continues to be a significantly deadly cancer with a cure rate of < 20% and a median survival of 6 - 9 months. The aggressiveness associated with metastatic melanoma is largely attributable to its inherent plasticity, a property that is mediated by the secretion of Nodal, a stem-cell associated protein belonging to the transforming growth factor-beta superfamily. This is supported by the observations that Nodal expression is limited to invasive vertical growth phase and metastatic melanoma lesions, and that inhibition of Nodal signaling promotes the reversion of metastatic melanoma cells toward a more differentiated, less invasive non-tumorigenic phenotype. Hence, due to its restricted expression pattern and function as a melanoma-tumor-promoter, Nodal (and its signaling partners) present unique targets for both immunologic and pharmacologic therapies.
Similar articles
- Role of nodal signaling and the microenvironment underlying melanoma plasticity.
Postovit LM, Margaryan NV, Seftor EA, Hendrix MJ. Postovit LM, et al. Pigment Cell Melanoma Res. 2008 Jun;21(3):348-57. doi: 10.1111/j.1755-148X.2008.00463.x. Epub 2008 Apr 26. Pigment Cell Melanoma Res. 2008. PMID: 18444961 Review. - Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.
Hardy KM, Strizzi L, Margaryan NV, Gupta K, Murphy GF, Scolyer RA, Hendrix MJ. Hardy KM, et al. Mol Cancer Res. 2015 Apr;13(4):670-80. doi: 10.1158/1541-7786.MCR-14-0077. Epub 2015 Mar 12. Mol Cancer Res. 2015. PMID: 25767211 Free PMC article. - The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH, Croteau W, Mullins DW, Brinckerhoff CE. Jenkins MH, et al. Matrix Biol. 2015 Oct;48:66-77. doi: 10.1016/j.matbio.2015.05.007. Epub 2015 May 16. Matrix Biol. 2015. PMID: 25989506 Free PMC article. - Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells.
Li H, Chen J, Wang X, He M, Zhang Z, Cen Y. Li H, et al. Oncol Rep. 2018 Jun;39(6):2855-2864. doi: 10.3892/or.2018.6387. Epub 2018 Apr 23. Oncol Rep. 2018. PMID: 29693169 - Reprogramming metastatic tumour cells with embryonic microenvironments.
Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, Postovit LM. Hendrix MJ, et al. Nat Rev Cancer. 2007 Apr;7(4):246-55. doi: 10.1038/nrc2108. Nat Rev Cancer. 2007. PMID: 17384580 Review.
Cited by
- Vascular mimicry: Triggers, molecular interactions and in vivo models.
Wechman SL, Emdad L, Sarkar D, Das SK, Fisher PB. Wechman SL, et al. Adv Cancer Res. 2020;148:27-67. doi: 10.1016/bs.acr.2020.06.001. Epub 2020 Jul 16. Adv Cancer Res. 2020. PMID: 32723566 Free PMC article. Review. - Low oxygen levels induce the expression of the embryonic morphogen Nodal.
Quail DF, Taylor MJ, Walsh LA, Dieters-Castator D, Das P, Jewer M, Zhang G, Postovit LM. Quail DF, et al. Mol Biol Cell. 2011 Dec;22(24):4809-21. doi: 10.1091/mbc.E11-03-0263. Epub 2011 Oct 26. Mol Biol Cell. 2011. PMID: 22031289 Free PMC article. - Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.
Mimeault M, Batra SK. Mimeault M, et al. World J Clin Oncol. 2012 Mar 10;3(3):32-42. doi: 10.5306/wjco.v3.i3.32. World J Clin Oncol. 2012. PMID: 22442756 Free PMC article. - Exploiting the convergence of embryonic and tumorigenic signaling pathways to develop new therapeutic targets.
Abbott DE, Postovit LM, Seftor EA, Margaryan NV, Seftor RE, Hendrix MJ. Abbott DE, et al. Stem Cell Rev. 2007 Jan;3(1):68-78. doi: 10.1007/s12015-007-0010-x. Stem Cell Rev. 2007. PMID: 17873384 Review. - Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway.
Quail DF, Zhang G, Findlay SD, Hess DA, Postovit LM. Quail DF, et al. Oncogene. 2014 Jan 23;33(4):461-73. doi: 10.1038/onc.2012.608. Epub 2013 Jan 21. Oncogene. 2014. PMID: 23334323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical